The role of gut hormones in appetite regulation (review)

Acta Physiologica Hungarica

Volumn 101, Issue 4, 2014, Pages 395-407

  Maric G ^a   Gazibara, T ^a   Zaletel, I ^a   Labudovic Borovic M ^a   Tomanovic N ^a   Ciric M ^b   Puškaš, Nela ^a,c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c Faculty of Medicine   (Serbia)

Author keywords

appetite; cholecystokinin; endocannabinoids; ghrelin; glucagon like peptide 1; oxyntomodulin; pancreatic polypeptide; peptide tyrosine tyrosine

Indexed keywords

CHOLECYSTOKININ; ENDOCANNABINOID; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY;

AMYGDALOID NUCLEUS; BODY WEIGHT; EATING; FOOD INTAKE; HUMAN; HYPOTHALAMUS; OBESITY; REVIEW; VAGUS NERVE DORSAL NUCLEUS; ANIMAL; FEEDING BEHAVIOR; GASTROINTESTINAL TRACT; INNERVATION; METABOLISM; PSYCHOLOGY; SIGNAL TRANSDUCTION; VAGUS NERVE;

ANIMALS; APPETITE REGULATION; EATING; FEEDING BEHAVIOR; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; HYPOTHALAMUS; OBESITY; SIGNAL TRANSDUCTION; VAGUS NERVE;

EID: 84919819623     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.101.2014.4.1     Document Type: Review

References (128)

1. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz PH, Barnes AJ: Distribution and release of human pancreatic polypeptide. Gut 17, 940-944 (1976)
2. Anand BK, Brobeck JR: Hypothalamic control of food intake in rats and cats. Yale J. Biol. Med. 24, 123-140 (1951)
3. Antin J, Gibbs J, Holt J, Young RC, Smith GP: Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J. Comp. Physiol. Psychol. 89, e784-e790 (1975)
4. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, Kasuga M: Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124, 1325-1336 (2003)
5. Baggio LL, Huang Q, Brown TJ, Drucker DJ: Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127, 546-558 (2004)
6. Bailey AR, von Engelhardt N, Leng G, Smith RG, Dickson SL: Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway. J. Neuroendocrinol. 12, 191-197 (2000)
7. Balasubramaniam A, Mullins DE, Lin S, Zhai W, Tao Z, Dhawan VC, Guzzi M, Knittel JJ, Slack K, Herzog H, Parker EM: Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affnity. J. Med. Chem. 49, 2661-2665 (2006)
8. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418, 650-654 (2002)
9. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD, Withers DJ: Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 4, 223-233 (2006)
10. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR: Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 88, 3989-3992 (2003)
11. Beglinger C, Degen L, Matzinger D, D'Amato M, Drewe J: Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1149-R1154 (2001)
12. Bellinger LL, Bernardis LL: The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol. Behav. 76, 431-442 (2002)
13. Berthoud HR: Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev. 26, 393-428 (2002)
14. Boswell T, Li Q, Takeuchi S: Neurons expressing neuropeptide Y mRNA in the infundibular hypothalamus of Japanese quail are activated by fasting and co-express agouti-related protein mRNA. Brain Res. Mol. Brain Res. 100, 31-42 (2002)
15. Carter ME, Soden ME, Zweifel LS, Palmiter RD: Genetic identifcation of a neural circuit that suppresses appetite. Nature 503, 111-114 (2013)
16. Centers for Disease Control and Prevention (CDC). Chronic Disease Prevention and Health Promotion. Obesity-Halting the Epidemic by Making Health Easier At A Glance 2011 Available at: http://www.cdc.gov/chronicdisease/resources/publications/aag/obesity.htm
17. Centers for Disease Control and Prevention (CDC). Overweight and Obesity Factsheet. Available at http://www. cdc.gov/obesity/data/facts.html
18. Chelikani PK, Haver AC, Reidelberger RD: Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146, 879-888 (2005)
19. Ciof P: The arcuate nucleus as a circumventricular organ in the mouse. Neurosci. Lett. 487, 187-190 (2011)
20. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR: Oxyntomodulin suppresses appetite and reduces food intake in humans. J. Clin. Endocrinol. Metab. 88, e4696-e4701 (2003)
21. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ: The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25 (Suppl 5), S63-S67 (2001)
22. Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL, Cone RD, Low MJ: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484 (2001)
23. Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661 (2003)
24. Cristino L, Busetto G, Imperatore R, Ferrandino I, Palomba L, Silvestri C, Petrosino S, Orlando P, Bentivoglio M, Mackie K, Di Marzo V: Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc. Natl Acad. Sci. USA 110, E2229-E2238 (2013)
25. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719 (2001)
26. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623-1630 (2002)
27. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, Bloom SR: Oxyntomodulin inhibits food intake in the rat. Endocrinology 142, 4244-4250 (2001)
28. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR: Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145, 2687-2695 (2004)
29. Di Marzo V: Endocannabinoids: an appetite for fat. Proc. Natl. Acad. Sci. USA 108, 12567-12568 (2011)
30. Diz-Chaves Y: Ghrelin, appetite regulation, and food reward: interaction with chronic stress. Inter. J. Pept. 2011, 898450 (2011)
31. Doyle ME, Egan JM: Glucagon-like peptide-1. Recent Prog. Horm. Res. 56, 377-399 (2001)
32. Druce MR, Minnion JS, Field BC, Patel SR, Shillito JC, Tilby M, Beale KE, Murphy KG, Ghatei MA, Bloom SR: Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogs. Endocrinology 150, 1712-1722 (2009)
33. Dufresne M, Seva C, Fourmy D: Cholecystokinin and gastrin receptors. Physiol. Rev. 86, 805-847 (2006)
34. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK: Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21, 1375-1385 (1998)
35. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE: Effect of macronutrient composition on postprandial peptide YY levels. J. Clin. Endocrinol. Metab. 92, 4052-4055 (2007)
36. Fehmann HC, Habener JF: Insulinotropic glucagon-like peptide-I(7-37)/(7-36)amide A new incretin hormone. Trends Endocrinol. Metab. 3, 158-163 (1992)
37. Ganaraj B, Jeganathan PS: Involvement of basolateral nucleus & central nucleus of amygdala in the regulation of ingestive behaviour in rat. Indian J. Med. Res. 108, 98-103 (1998)
38. Gazibara T, Kisic Tepavcevic DB, Popovic A, Pekmezovic T: Eating habits and body-weights of students of the University of Belgrade, Serbia: a cross-sectional study. J. Health Popul. Nutr. 31, 330-333 (2013)
39. Gibbons C, Caudwell P, Finlayson G, Webb D-L, Hellström PM, Näslund E, Blundell JE: Comparison of postprandial profles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J. Clin. Endocrinol. Metab. 98, 847-855 (2013)
40. Gibbs J, Young RC, Smith GP: Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84, 488-495 (1973)
41. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR Jr: Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul. Pept. 51, 151-159 (1994)
42. Greenberg GR, McCloy RF, Adrian TE, Chadwick VS, Baron JH, Bloom SR: Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 2, 1280-1282 (1978)
43. Grill HJ, Kaplan JM: The neuroanatomical axis for control of energy balance. Front. Neuroendocrinol. 23, 2-40 (2002)
44. Hahn TM, Breininger JF, Baskin DG, Schwartz MW: Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosc. 1, 271-272 (1998)
45. Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R, Göke B: Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56, 117-126 (1995)
46. Hetherington AW, Ranson SW: Experimental hypothalamico-hypophyseal obesity in the rat. Proc. Soc. Exp. Biol. Med. 41, 465-466 (1939)
47. Hewson AK, Dickson SL: Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J. Neuroendocrinol. 12, 1047-1049 (2000)
48. Holst JJ: The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439 (2007)
49. Honda K, Saneyasu T, Yamaguchi T, Shimatani T, Aoki K, Nakanishi K, Kamisoyama H: Intracerebroventricular administration of chicken oxyntomodulin suppresses food intake and increases plasma glucose and cortico-sterone concentrations in chicks. Neurosci. Lett. 564, 57-61 (2014)
50. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfeld LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141 (1997)
51. Imeryüz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Peñacarrillo ML, Ulusoy NB: Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 273, G920-G927 (1997)
52. Institute of Public Health of Serbia. National Health Survey Serbia-Key fndings. (2006) Available at: http://www.batut.org.rs/download/publikacije/National%20Health%20Survey%20Serbia%202006.pdf
53. 2+ signaling in nodose ganglion neurons. Neuropeptides 47, 19-23 (2013)
54. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS: Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl Acad. Sci. USA 88, 10931-10935 (1991)
55. Kanaley JA, Heden TD, Liu Y, Whaley-Connell AT, Chockalingam A, Dellsperger KC, Fairchild TJ: Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals. Int. J. Obes. (Lond) 38, 266-271 (2014)
56. Keire DA, Mannon P, Kobayashi M, Walsh JH, Solomon TE, Reeve JR Jr: Primary structures of PYY, [Pro(34)] PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G126-G131 (2000)
57. Kihira Y, Miyake M, Hirata M, Hoshina Y, Kato K, Shirakawa H, Sakaue H, Yamano N, Izawa-Ishizawa Y, Ishizawa K, Ikeda Y, Tsuchiya K, Tamaki T, Tomita S: Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue infammation. PLoS One 9, e93856 (2014)
58. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP: C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 34, 154-160 (1981)
59. Kohno D, Yada T: Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Neuropeptides 46, 315-319 (2012)
60. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660 (1999)
61. Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S: Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. Diabetes 38, 902-905 (1989)
62. Körner M, Stöckli M, Waser B, Reubi JC: GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J. Nucl. Med. 48, 736-743 (2007)
63. Kosinski JR, Hubert J, Carrington PE, Chicchi GG, Mu J, Miller C, Cao J, Bianchi E, Pessi A, Sinharoy R, Marsh DJ, Pocai A: The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin. Obesity 20, 1566-1571 (2012)
64. Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS, Maratos-Flier E, Roth BL, Lowell BB: Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121, 1424-1428 (2011)
65. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393, 72-76 (1998)
66. Lawrence CB, Snape AC, Baudoin FM, Luckman SM: Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143, 155-162 (2002)
67. Leibowitz SF, Hammer NJ, Chang K: Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol. Behav. 27, 1031-1040 (1981)
68. Lénárd L, Karádi Z: Regulatory processes of hunger motivated behavior. Acta Biol. Hung. 63, (Suppl 1) 80-88 (2012)
69. Lieverse RJ, Jansen JB, Masclee AA, Lamers CB: Satiety effects of a physiological dose of cholecystokinin in humans. Gut 36, 176-179 (1995)
70. Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB: Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 35, 501-505 (1994)
71. Lin S, Boey D, Herzog H: NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38, 189-200 (2004)
72. Lin S, Shi YC, Yulyaningsih E, Aljanova A, Zhang L, Macia L, Nguyen AD, Lin EJ, During MJ, Herzog H, Sainsbury A: Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. PLoS One 4, e8488 (2009)
73. Little TJ, McKie S, Jones RB, D'Amato M, Smith C, Kiss O, Thompson DG, McLaughlin JT: Mapping glucose-mediated gut-to-brain signalling pathways in humans. Neuroimage pii: S1053-8119(14)00220-1 (2014)
74. Liu CD, Aloia T, Adrian TE, Newton TR, Bilchik AJ, Zinner MJ, Ashley SW, McFadden DW: Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders. Am. Surg. 62, 232-236 (1996)
75. Lund MT, Taudorf L, Hartmann B, Helge JW, Holst JJ, Dela F: Meal induced gut hormone secretion is altered in aerobically trained compared to sedentary young healthy males. Eur. J. Appl. Physiol. 113, 2737-2747 (2013)
76. Maida A, Lovshin JA, Baggio LL, Drucker DJ: The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. Endocrinology 149, 5670-5678 (2008)
77. Malaisse-Lagae F, Carpentier JL, Patel YC, Malaisse WJ, Orci L: Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia 33, 915-917 (1977)
78. Matson CA, Reid DF, Cannon TA, Ritter RC: Cholecystokinin and leptin act synergistically to reduce body weight. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R882-R890 (2000)
79. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR: Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140, 244-250 (1999)
80. Moran TH, Robinson PH, Goldrich MS, McHugh PR: Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362, 175-179 (1986)
81. Mountjoy KG: Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem. J. 428, 305-324 (2010)
82. Nagatake T, Fujita H, Minato N, Hamazaki Y: Enteroendocrine cells are specifcally marked by cell surface expression of claudin-4 in mouse small intestine. PLoS One 9, e90638 (2014)
83. Nijenhuis WA, Oosterom J, Adan RA: AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15, 164-171 (2001)
84. Novakovic I, Maksimovic N, Pavlovic A, Zarkovic M, Rovcanin B, Mirkovic D, Pekmezovic T, Cvetkovic D: Introduction to molecular genetic diagnostics. J. Med. Biochem. 33, 3-7 (2014)
85. Oomura Y, Aou S, Fukunaga K: Prandial increase of leptin in the brain activates spatial learning and memory. Pathophysiology 17, 119-127 (2010)
86. Palkovits M: Hypothalamic regulation of food intake. Ideggyógy Sz. 56, 288-302 (2003)
87. Pekmezovic T: Gene-environment interaction: a genetic-epidemiological approach. J. Med. Biochem. 29, 1-5 (2010)
88. Pertwee RG: Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 367, 3353-3363 (2012)
89. Pitkanen A (2000): Connectivity of the rat amygdaloid complex. In: The Amygdala: A functional analysis, ed Aggleton JP, Oxford University Press, Oxford, pp. 31-115
90. Polak JM, Bloom SR, Rayford PL, Pearse AG, Buchan AM, Thompson JC: Identifcation of cholecystokinin-secreting cells. Lancet 2, 1016-1018 (1975)
91. Pritchard LE, Turnbull AV, White A: Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 172, 411-421 (2002)
92. Puškaš L, Puškaš N, Todorovic V, Labudovic-Borovic M, Dulejic V: Distribution of CB1 cannabinoid receptors in the rat amygdaloid complex. Acta Veterinaria 54, 369-378 (2004)
93. Puskas N (2010): Effect of subdiaphragmatic vagotomy on fasting-and refeeding-elicited neuronal activity in the dorsal vagal complex of rats with and without monosodium glutamate pretreatment. Doctoral dissertation, Faculty of Medicine, University of Belgrade
94. Puskas N, Papp RS, Gallatz K, Palkovits M: Interactions between orexin-immunoreactive fbers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides 31, 1589-1597 (2010)
95. Puškaš N, Puškaš L, Draganic-Gajic S, Dulejic V, Babic Z, Bajcetic M: Morphology, size and distribution of Corticotropin Releasing Factor (CRF) immunoreactive neurons in the central nucleus of the rat amygdaloid complex. Acta Veterinaria 56, 449-456 (2006)
96. Puškaš N, Puškaš L, Malobabic S, Dulejic V, Todorovic V: Localisation and morphology of Cocaine-and Amphetamine Regulated Transcript (CART) peptide immunoreactive neurons in rat amygdala. Acta Veterinaria 55, 423-434 (2005)
97. Pyke C, Heller RS, Kirk RK, Orskov C, Reedtz-Runge S, Kaastrup P, Hvelplund A, Bardram L, Calatayud D, Knudsen LB: GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 155, 1280-1290 (2014)
98. Ramírez S, Martins L, Jacas J, Carrasco P, Pozo M, Clotet J, Serra D, Hegardt FG, Diéguez C, López M, Casals N: Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes 62, 2329-2337 (2013)
99. Renner E, Puskás N, Dobolyi A, Palkovits M: Glucagon-like peptide-1 of brainstem origin activates dorsomedial hypothalamic neurons in satiated rats. Peptides 35, 14-22 (2012)
100. Renner E, Szabó-Meltzer KI, Puskás N, Tóth ZE, Dobolyi A, Palkovits M: Activation of neurons in the hypothalamic dorsomedial nucleus via hypothalamic projections of the nucleus of the solitary tract following refeeding of fasted rats. Eur. J. Neurosci. 31, 302-314 (2010)
101. Ricardo JA, Koh ET: Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 153, 1-26 (1978)
102. Rodríguez EM, Blázquez JL, Guerra M: The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fuid. Peptides 31, 757-776 (2010)
103. Roseberry AG, Liu H, Jackson AC, Cai X, Friedman JM: Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41, 711-722 (2004)
104. Rüter J, Kobelt P, Tebbe JJ, Avsar Y, Veh R, Wang L, Klapp BF, Wiedenmann B, Taché Y, Mönnikes H: Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats. Brain Res. 991, 26-33 (2003)
105. Sam AH, Troke RC, Tan TM, Bewick GA: The role of the gut/brain axis in modulating food intake. Neuropharmacology 63, 46-56 (2012)
106. Sanger GJ: Endocannabinoids and the gastrointestinal tract: what are the key questions? Br. J. Pharmacol. 152, 663-670 (2007)
107. Schaeffer M, Langlet F, Lafont C, Molino F, Hodson DJ, Roux T, Lamarque L, Verdié P, Bourrier E, Dehouck B, Banères JL, Martinez J, Méry PF, Marie J, Trinquet E, Fehrentz JA, Prévot V, Mollard P: Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl Acad. Sci. USA 110, 1512-1517 (2013)
108. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature 404, 661-671 (2000)
109. Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, de Muckadell OB, Stadil F: Vagal, cholinergic regulation of pancreatic polypeptide secretion. J. Clin. Invest. 61, 781-789 (1978)
110. Schwizer W, Borovicka J, Kunz P, Fraser R, Kreiss C, D'Amato M, Crelier G, Boesiger P, Fried M: Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 41, 500-504 (1997)
111. Shi YC, Lin Z, Lau J, Zhang H, Yagi M, Kanzler I, Sainsbury A, Herzog H, Lin S: PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice. Obesity (Silver Spring) 21, E669-E678 (2013)
112. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50, 227-232 (2001)
113. Shughrue PJ, Lane MV, Merchenthaler I: Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 137, 5159-5162 (1996)
114. Sloth B, Holst JJ, Flint A, Gregersen NT, Astrup A: Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am. J. Physiol. Endocrinol. Metab. 292, E1062-E1068 (2007)
115. Stadlbauer U, Arnold M, Weber E, Langhans W: Possible mechanisms of circulating PYY-induced satiation in male rats. Endocrinology 154, 193-204 (2013)
116. Stanic D, Brumovsky P, Fetissov S, Shuster S, Herzog H, Hökfelt T: Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J. Comp. Neurol. 499, 357-390 (2006)
117. Stevanovic D, Trajkovic V, Müller-Lühlhoff S, Brandt E, Abplanalp W, Bumke-Vogt C, Liehl B, Wiedmer P, Janjetovic K, Starcevic V, Pfeiffer AF, Al-Hasani H, Tschöp MH, Castañeda TR: Ghrelin-induced food intake and adiposity depend on central mTORC1/S6K1 signaling. Mol. Cell Endocrinol. 381, 280-290 (2013)
118. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR: The role of gut hormones and the hypothalamus in appetite regulation. Endocr. J. 57, 359-372 (2010)
119. Sykaras AGL, Demenis C, Case RM, McLaughlin JT, Smith CP: Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One 7, e42373 (2012)
120. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL: Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146, 3748-3756 (2005)
121. Tang-Christensen M, Vrang N, Larsen PJ: Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int. J. Obes. Relat. Metab. Disord. 25, (Suppl. 5), S42-S47 (2001)
122. Troke RC, Tan TM, Bloom SR: The future role of gut hormones in the treatment of obesity. Ther. Adv. Chronic. Dis. 5, 4-14 (2014)
123. Vahl TP, Drazen DL, Seeley RJ, D'Alessio DA, Woods SC: Meal-anticipatory glucagon-like peptide-1 secretion in rats. Endocrinology 151, 569-575 (2010)
124. Van der Klaauw AA, Keogh JM, Henning E, Trowse VM, Dhillo WS, Ghatei MA, Faroogi IS: High protein intake stimulates postprandial GLP1 and PYY release. Obesity 21, 1602-1607 (2013)
125. Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ: PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R367-R375 (2006)
126. Wynne K, Park AJ, Small CJ, Meeran K, Ghatei MA, Frost GS, Bloom SR: Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int. J. Obes. (Lond) 30, e1729-e1736 (2006)
127. Yamamoto T: Central mechanisms of roles of taste in reward and eating. Acta Physiol. Hung. 95, 165-186 (2008)
128. Yulyaningsih E, Loh K, Lin S, Lau J, Zhang L, Shi Y, Berning BA, Enriquez R, Driessler F, Macia L, Khor EC, Qi Y, Baldock P, Sainsbury A, Herzog H. Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice. Cell Metab. 19, 58-72 (2014)